▶ 調査レポート

ソタロールのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Sotalol Market Insights and Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ソタロールのグローバル市場インサイト・予測(~2028年) / Global Sotalol Market Insights and Forecast to 2028 / QY2203B03860資料のイメージです。• レポートコード:QY2203B03860
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥686,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,029,000 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,372,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のソタロールの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にソタロールの世界市場のxxx%を占める「ソタロール40mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「持続性心室頻拍」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のソタロールの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのソタロール市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのソタロール市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ソタロールのグローバル主要メーカーには、Bayer、GSK、Bristol-Myers Squibb(BMS)、Arbor Pharmaceuticals、Cambrex、Arevipharma、Shaanxi Hanjiang Pharmaceutical Group、Samarth Pharma Pvt. Ltd.、Cipla Limitedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ソタロール市場は、種類と用途によって区分されます。世界のソタロール市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ソタロール40mg、ソタロール80mg

【用途別セグメント】
持続性心室頻拍、心房細動・粗動

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ソタロール製品概要
- 種類別市場(ソタロール40mg、ソタロール80mg)
- 用途別市場(持続性心室頻拍、心房細動・粗動)
- 調査の目的
・エグゼクティブサマリー
- 世界のソタロール販売量予測2017-2028
- 世界のソタロール売上予測2017-2028
- ソタロールの地域別販売量
- ソタロールの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ソタロール販売量
- 主要メーカー別ソタロール売上
- 主要メーカー別ソタロール価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(ソタロール40mg、ソタロール80mg)
- ソタロールの種類別販売量
- ソタロールの種類別売上
- ソタロールの種類別価格
・用途別市場規模(持続性心室頻拍、心房細動・粗動)
- ソタロールの用途別販売量
- ソタロールの用途別売上
- ソタロールの用途別価格
・北米市場
- 北米のソタロール市場規模(種類別、用途別)
- 主要国別のソタロール市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのソタロール市場規模(種類別、用途別)
- 主要国別のソタロール市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のソタロール市場規模(種類別、用途別)
- 主要国別のソタロール市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のソタロール市場規模(種類別、用途別)
- 主要国別のソタロール市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのソタロール市場規模(種類別、用途別)
- 主要国別のソタロール市場規模(トルコ、サウジアラビア)
・企業情報
Bayer、GSK、Bristol-Myers Squibb(BMS)、Arbor Pharmaceuticals、Cambrex、Arevipharma、Shaanxi Hanjiang Pharmaceutical Group、Samarth Pharma Pvt. Ltd.、Cipla Limited
・産業チェーン及び販売チャネル分析
- ソタロールの産業チェーン分析
- ソタロールの原材料
- ソタロールの生産プロセス
- ソタロールの販売及びマーケティング
- ソタロールの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ソタロールの産業動向
- ソタロールのマーケットドライバー
- ソタロールの課題
- ソタロールの阻害要因
・主な調査結果

Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties.
Market Analysis and Insights: Global Sotalol Market
Due to the COVID-19 pandemic, the global Sotalol market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 40mg Sotalol accounting for % of the Sotalol global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Sustained Ventricular Tachycardia segment is altered to an % CAGR throughout this forecast period.
China Sotalol market size is valued at US$ million in 2021, while the US and Europe Sotalol are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Sotalol landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Sotalol include Bayer, GSK, Bristol-Myers Squibb(BMS), Arbor Pharmaceuticals, Cambrex, Arevipharma, Shaanxi Hanjiang Pharmaceutical Group, Samarth Pharma Pvt. Ltd. and Cipla Limited. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Sotalol Scope and Segment
Sotalol market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Sotalol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
40mg Sotalol
80mg Sotalol
Segment by Application
Sustained Ventricular Tachycardia
Atrial Fibrillation/Flutter
By Company
Bayer
GSK
Bristol-Myers Squibb(BMS)
Arbor Pharmaceuticals
Cambrex
Arevipharma
Shaanxi Hanjiang Pharmaceutical Group
Samarth Pharma Pvt. Ltd.
Cipla Limited
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

1 Study Coverage
1.1 Sotalol Product Introduction
1.2 Market by Type
1.2.1 Global Sotalol Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 40mg Sotalol
1.2.3 80mg Sotalol
1.3 Market by Application
1.3.1 Global Sotalol Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Sustained Ventricular Tachycardia
1.3.3 Atrial Fibrillation/Flutter
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sotalol Sales Estimates and Forecasts 2017-2028
2.2 Global Sotalol Revenue Estimates and Forecasts 2017-2028
2.3 Global Sotalol Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sotalol Sales by Region
2.4.1 Global Sotalol Sales by Region (2017-2022)
2.4.2 Global Sales Sotalol by Region (2023-2028)
2.5 Global Sotalol Revenue by Region
2.5.1 Global Sotalol Revenue by Region (2017-2022)
2.5.2 Global Sotalol Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sotalol Sales by Manufacturers
3.1.1 Global Top Sotalol Manufacturers by Sales (2017-2022)
3.1.2 Global Sotalol Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sotalol in 2021
3.2 Global Sotalol Revenue by Manufacturers
3.2.1 Global Sotalol Revenue by Manufacturers (2017-2022)
3.2.2 Global Sotalol Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sotalol Revenue in 2021
3.3 Global Sotalol Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sotalol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sotalol Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sotalol Sales by Type
4.1.1 Global Sotalol Historical Sales by Type (2017-2022)
4.1.2 Global Sotalol Forecasted Sales by Type (2023-2028)
4.1.3 Global Sotalol Sales Market Share by Type (2017-2028)
4.2 Global Sotalol Revenue by Type
4.2.1 Global Sotalol Historical Revenue by Type (2017-2022)
4.2.2 Global Sotalol Forecasted Revenue by Type (2023-2028)
4.2.3 Global Sotalol Revenue Market Share by Type (2017-2028)
4.3 Global Sotalol Price by Type
4.3.1 Global Sotalol Price by Type (2017-2022)
4.3.2 Global Sotalol Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Sotalol Sales by Application
5.1.1 Global Sotalol Historical Sales by Application (2017-2022)
5.1.2 Global Sotalol Forecasted Sales by Application (2023-2028)
5.1.3 Global Sotalol Sales Market Share by Application (2017-2028)
5.2 Global Sotalol Revenue by Application
5.2.1 Global Sotalol Historical Revenue by Application (2017-2022)
5.2.2 Global Sotalol Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sotalol Revenue Market Share by Application (2017-2028)
5.3 Global Sotalol Price by Application
5.3.1 Global Sotalol Price by Application (2017-2022)
5.3.2 Global Sotalol Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sotalol Market Size by Type
6.1.1 North America Sotalol Sales by Type (2017-2028)
6.1.2 North America Sotalol Revenue by Type (2017-2028)
6.2 North America Sotalol Market Size by Application
6.2.1 North America Sotalol Sales by Application (2017-2028)
6.2.2 North America Sotalol Revenue by Application (2017-2028)
6.3 North America Sotalol Market Size by Country
6.3.1 North America Sotalol Sales by Country (2017-2028)
6.3.2 North America Sotalol Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Sotalol Market Size by Type
7.1.1 Europe Sotalol Sales by Type (2017-2028)
7.1.2 Europe Sotalol Revenue by Type (2017-2028)
7.2 Europe Sotalol Market Size by Application
7.2.1 Europe Sotalol Sales by Application (2017-2028)
7.2.2 Europe Sotalol Revenue by Application (2017-2028)
7.3 Europe Sotalol Market Size by Country
7.3.1 Europe Sotalol Sales by Country (2017-2028)
7.3.2 Europe Sotalol Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sotalol Market Size by Type
8.1.1 Asia Pacific Sotalol Sales by Type (2017-2028)
8.1.2 Asia Pacific Sotalol Revenue by Type (2017-2028)
8.2 Asia Pacific Sotalol Market Size by Application
8.2.1 Asia Pacific Sotalol Sales by Application (2017-2028)
8.2.2 Asia Pacific Sotalol Revenue by Application (2017-2028)
8.3 Asia Pacific Sotalol Market Size by Region
8.3.1 Asia Pacific Sotalol Sales by Region (2017-2028)
8.3.2 Asia Pacific Sotalol Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Sotalol Market Size by Type
9.1.1 Latin America Sotalol Sales by Type (2017-2028)
9.1.2 Latin America Sotalol Revenue by Type (2017-2028)
9.2 Latin America Sotalol Market Size by Application
9.2.1 Latin America Sotalol Sales by Application (2017-2028)
9.2.2 Latin America Sotalol Revenue by Application (2017-2028)
9.3 Latin America Sotalol Market Size by Country
9.3.1 Latin America Sotalol Sales by Country (2017-2028)
9.3.2 Latin America Sotalol Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sotalol Market Size by Type
10.1.1 Middle East and Africa Sotalol Sales by Type (2017-2028)
10.1.2 Middle East and Africa Sotalol Revenue by Type (2017-2028)
10.2 Middle East and Africa Sotalol Market Size by Application
10.2.1 Middle East and Africa Sotalol Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sotalol Revenue by Application (2017-2028)
10.3 Middle East and Africa Sotalol Market Size by Country
10.3.1 Middle East and Africa Sotalol Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sotalol Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bristol-Myers Squibb(BMS)
11.3.1 Bristol-Myers Squibb(BMS) Corporation Information
11.3.2 Bristol-Myers Squibb(BMS) Overview
11.3.3 Bristol-Myers Squibb(BMS) Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb(BMS) Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb(BMS) Recent Developments
11.4 Arbor Pharmaceuticals
11.4.1 Arbor Pharmaceuticals Corporation Information
11.4.2 Arbor Pharmaceuticals Overview
11.4.3 Arbor Pharmaceuticals Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Arbor Pharmaceuticals Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Arbor Pharmaceuticals Recent Developments
11.5 Cambrex
11.5.1 Cambrex Corporation Information
11.5.2 Cambrex Overview
11.5.3 Cambrex Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cambrex Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cambrex Recent Developments
11.6 Arevipharma
11.6.1 Arevipharma Corporation Information
11.6.2 Arevipharma Overview
11.6.3 Arevipharma Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Arevipharma Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Arevipharma Recent Developments
11.7 Shaanxi Hanjiang Pharmaceutical Group
11.7.1 Shaanxi Hanjiang Pharmaceutical Group Corporation Information
11.7.2 Shaanxi Hanjiang Pharmaceutical Group Overview
11.7.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments
11.8 Samarth Pharma Pvt. Ltd.
11.8.1 Samarth Pharma Pvt. Ltd. Corporation Information
11.8.2 Samarth Pharma Pvt. Ltd. Overview
11.8.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Samarth Pharma Pvt. Ltd. Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Samarth Pharma Pvt. Ltd. Recent Developments
11.9 Cipla Limited
11.9.1 Cipla Limited Corporation Information
11.9.2 Cipla Limited Overview
11.9.3 Cipla Limited Sotalol Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cipla Limited Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cipla Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sotalol Industry Chain Analysis
12.2 Sotalol Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sotalol Production Mode & Process
12.4 Sotalol Sales and Marketing
12.4.1 Sotalol Sales Channels
12.4.2 Sotalol Distributors
12.5 Sotalol Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sotalol Industry Trends
13.2 Sotalol Market Drivers
13.3 Sotalol Market Challenges
13.4 Sotalol Market Restraints
14 Key Findings in The Global Sotalol Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Sotalol Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 40mg Sotalol
Table 3. Major Manufacturers of 80mg Sotalol
Table 4. Global Sotalol Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Sotalol Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Sotalol Sales by Region (2017-2022) & (M Doses)
Table 7. Global Sotalol Sales Market Share by Region (2017-2022)
Table 8. Global Sotalol Sales by Region (2023-2028) & (M Doses)
Table 9. Global Sotalol Sales Market Share by Region (2023-2028)
Table 10. Global Sotalol Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Sotalol Revenue Market Share by Region (2017-2022)
Table 12. Global Sotalol Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Sotalol Revenue Market Share by Region (2023-2028)
Table 14. Global Sotalol Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Sotalol Sales Share by Manufacturers (2017-2022)
Table 16. Global Sotalol Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Sotalol Revenue Share by Manufacturers (2017-2022)
Table 18. Sotalol Price by Manufacturers (2017-2022) &(USD/K Doses)
Table 19. Global Sotalol Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Sotalol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sotalol as of 2021)
Table 21. Sotalol Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Sotalol Product Offered
Table 23. Date of Manufacturers Enter into Sotalol Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sotalol Sales by Type (2017-2022) & (M Doses)
Table 26. Global Sotalol Sales by Type (2023-2028) & (M Doses)
Table 27. Global Sotalol Sales Share by Type (2017-2022)
Table 28. Global Sotalol Sales Share by Type (2023-2028)
Table 29. Global Sotalol Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Sotalol Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Sotalol Revenue Share by Type (2017-2022)
Table 32. Global Sotalol Revenue Share by Type (2023-2028)
Table 33. Sotalol Price by Type (2017-2022) & (USD/K Doses)
Table 34. Global Sotalol Price Forecast by Type (2023-2028) & (USD/K Doses)
Table 35. Global Sotalol Sales by Application (2017-2022) & (M Doses)
Table 36. Global Sotalol Sales by Application (2023-2028) & (M Doses)
Table 37. Global Sotalol Sales Share by Application (2017-2022)
Table 38. Global Sotalol Sales Share by Application (2023-2028)
Table 39. Global Sotalol Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Sotalol Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Sotalol Revenue Share by Application (2017-2022)
Table 42. Global Sotalol Revenue Share by Application (2023-2028)
Table 43. Sotalol Price by Application (2017-2022) & (USD/K Doses)
Table 44. Global Sotalol Price Forecast by Application (2023-2028) & (USD/K Doses)
Table 45. North America Sotalol Sales by Type (2017-2022) & (M Doses)
Table 46. North America Sotalol Sales by Type (2023-2028) & (M Doses)
Table 47. North America Sotalol Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Sotalol Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Sotalol Sales by Application (2017-2022) & (M Doses)
Table 50. North America Sotalol Sales by Application (2023-2028) & (M Doses)
Table 51. North America Sotalol Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Sotalol Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Sotalol Sales by Country (2017-2022) & (M Doses)
Table 54. North America Sotalol Sales by Country (2023-2028) & (M Doses)
Table 55. North America Sotalol Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Sotalol Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Sotalol Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Sotalol Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Sotalol Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Sotalol Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Sotalol Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Sotalol Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Sotalol Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Sotalol Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Sotalol Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Sotalol Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Sotalol Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Sotalol Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Sotalol Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Sotalol Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Sotalol Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Sotalol Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Sotalol Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Sotalol Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Sotalol Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Sotalol Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Sotalol Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Sotalol Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Sotalol Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Sotalol Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Sotalol Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Sotalol Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Sotalol Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Sotalol Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Sotalol Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Sotalol Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Sotalol Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Sotalol Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Sotalol Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Sotalol Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Sotalol Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Sotalol Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Sotalol Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Sotalol Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Sotalol Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Sotalol Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Sotalol Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Sotalol Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Sotalol Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Sotalol Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Sotalol Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Sotalol Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Sotalol Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Sotalol Revenue by Country (2023-2028) & (US$ Million)
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Major Businesses
Table 107. Bayer Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 108. Bayer Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Bayer Recent Developments
Table 110. GSK Corporation Information
Table 111. GSK Description and Major Businesses
Table 112. GSK Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 113. GSK Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GSK Recent Developments
Table 115. Bristol-Myers Squibb(BMS) Corporation Information
Table 116. Bristol-Myers Squibb(BMS) Description and Major Businesses
Table 117. Bristol-Myers Squibb(BMS) Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 118. Bristol-Myers Squibb(BMS) Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bristol-Myers Squibb(BMS) Recent Developments
Table 120. Arbor Pharmaceuticals Corporation Information
Table 121. Arbor Pharmaceuticals Description and Major Businesses
Table 122. Arbor Pharmaceuticals Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 123. Arbor Pharmaceuticals Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Arbor Pharmaceuticals Recent Developments
Table 125. Cambrex Corporation Information
Table 126. Cambrex Description and Major Businesses
Table 127. Cambrex Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 128. Cambrex Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Cambrex Recent Developments
Table 130. Arevipharma Corporation Information
Table 131. Arevipharma Description and Major Businesses
Table 132. Arevipharma Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 133. Arevipharma Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Arevipharma Recent Developments
Table 135. Shaanxi Hanjiang Pharmaceutical Group Corporation Information
Table 136. Shaanxi Hanjiang Pharmaceutical Group Description and Major Businesses
Table 137. Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 138. Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Shaanxi Hanjiang Pharmaceutical Group Recent Developments
Table 140. Samarth Pharma Pvt. Ltd. Corporation Information
Table 141. Samarth Pharma Pvt. Ltd. Description and Major Businesses
Table 142. Samarth Pharma Pvt. Ltd. Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 143. Samarth Pharma Pvt. Ltd. Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Samarth Pharma Pvt. Ltd. Recent Developments
Table 145. Cipla Limited Corporation Information
Table 146. Cipla Limited Description and Major Businesses
Table 147. Cipla Limited Sotalol Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 148. Cipla Limited Sotalol Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Cipla Limited Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Sotalol Distributors List
Table 153. Sotalol Customers List
Table 154. Sotalol Market Trends
Table 155. Sotalol Market Drivers
Table 156. Sotalol Market Challenges
Table 157. Sotalol Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Sotalol Product Picture
Figure 3. Global Sotalol Market Share by Type in 2021 & 2028
Figure 3. 40mg Sotalol Product Picture
Figure 4. 80mg Sotalol Product Picture
Figure 5. Global Sotalol Market Share by Application in 2021 & 2028
Figure 6. Sustained Ventricular Tachycardia
Figure 7. Atrial Fibrillation/Flutter
Figure 8. Sotalol Report Years Considered
Figure 9. Global Sotalol Sales 2017-2028 (M Doses)
Figure 10. Global Sotalol Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Sotalol Revenue 2017-2028 (US$ Million)
Figure 12. Global Sotalol Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Sotalol Sales Market Share by Region (2017-2022)
Figure 14. Global Sotalol Sales Market Share by Region (2023-2028)
Figure 15. North America Sotalol Sales YoY (2017-2028) & (M Doses)
Figure 16. North America Sotalol Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Sotalol Sales YoY (2017-2028) & (M Doses)
Figure 18. Europe Sotalol Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Sotalol Sales YoY (2017-2028) & (M Doses)
Figure 20. Asia-Pacific Sotalol Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Sotalol Sales YoY (2017-2028) & (M Doses)
Figure 22. Latin America Sotalol Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Sotalol Sales YoY (2017-2028) & (M Doses)
Figure 24. Middle East & Africa Sotalol Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Sotalol Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Sotalol in the World: Market Share by Sotalol Revenue in 2021
Figure 27. Global Sotalol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Sotalol Sales Market Share by Type (2017-2028)
Figure 29. Global Sotalol Revenue Market Share by Type (2017-2028)
Figure 30. Global Sotalol Sales Market Share by Application (2017-2028)
Figure 31. Global Sotalol Revenue Market Share by Application (2017-2028)
Figure 32. North America Sotalol Sales Market Share by Type (2017-2028)
Figure 33. North America Sotalol Revenue Market Share by Type (2017-2028)
Figure 34. North America Sotalol Sales Market Share by Application (2017-2028)
Figure 35. North America Sotalol Revenue Market Share by Application (2017-2028)
Figure 36. North America Sotalol Sales Share by Country (2017-2028)
Figure 37. North America Sotalol Revenue Share by Country (2017-2028)
Figure 38. U.S. Sotalol Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Sotalol Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Sotalol Sales Market Share by Type (2017-2028)
Figure 41. Europe Sotalol Revenue Market Share by Type (2017-2028)
Figure 42. Europe Sotalol Sales Market Share by Application (2017-2028)
Figure 43. Europe Sotalol Revenue Market Share by Application (2017-2028)
Figure 44. Europe Sotalol Sales Share by Country (2017-2028)
Figure 45. Europe Sotalol Revenue Share by Country (2017-2028)
Figure 46. Germany Sotalol Revenue (2017-2028) & (US$ Million)
Figure 47. France Sotalol Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Sotalol Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Sotalol Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Sotalol Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Sotalol Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Sotalol Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Sotalol Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Sotalol Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Sotalol Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Sotalol Revenue Share by Region (2017-2028)
Figure 57. China Sotalol Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Sotalol Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Sotalol Revenue (2017-2028) & (US$ Million)
Figure 60. India Sotalol Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Sotalol Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Sotalol Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Sotalol Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Sotalol Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Sotalol Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Sotalol Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Sotalol Sales Market Share by Type (2017-2028)
Figure 68. Latin America Sotalol Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Sotalol Sales Market Share by Application (2017-2028)
Figure 70. Latin America Sotalol Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Sotalol Sales Share by Country (2017-2028)
Figure 72. Latin America Sotalol Revenue Share by Country (2017-2028)
Figure 73. Mexico Sotalol Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Sotalol Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Sotalol Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Sotalol Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Sotalol Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Sotalol Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Sotalol Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Sotalol Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Sotalol Revenue Share by Country (2017-2028)
Figure 82. Turkey Sotalol Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Sotalol Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Sotalol Revenue (2017-2028) & (US$ Million)
Figure 85. Sotalol Value Chain
Figure 86. Sotalol Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed